Year |
Citation |
Score |
2020 |
Chung E, Choi Y, Park J, Nah W, Park J, Jung Y, Lee J, Lee H, Park S, Hwang S, Kim S, Lee J, Min D, Jo J, Kang S, ... ... Jo D, et al. Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological α-synuclein. Science Advances. 6: eaba1193. PMID 32494688 DOI: 10.1126/Sciadv.Aba1193 |
0.599 |
|
2018 |
Choi Y, Jung M, Shin S, Lee K, Jo D. Abstract LB-010: Intracellular delivery of SOCS3 suppresses solid tumor progression Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Lb-010 |
0.484 |
|
2018 |
Shin S, Lee K, Hwang Y, Choi Y, Jo D. Abstract LB-008: Intracellular delivery of SOCS3 suppresses hepatocelluar carcinoma progression Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Lb-008 |
0.486 |
|
2018 |
Lee K, Shin S, Hwang Y, Choi Y, Jo D. Abstract LB-007: Intracellular delivery of SOCS3 suppresses pancreatic cancer progression Cancer Research. 78: 4653-4653. DOI: 10.1158/1538-7445.Am2018-Lb-007 |
0.511 |
|
2018 |
Choi Y, Shin S, Lee K, Jo D. Abstract LB-006: Intracellular protein therapy with SOCS3 utilizing aMTD-enabled macromolecule intracellular transduction technology (MITT) Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Lb-006 |
0.514 |
|
2014 |
Duong T, Kim J, Ruley HE, Jo D. Cell-permeable parkin proteins suppress Parkinson disease-associated phenotypes in cultured cells and animals. Plos One. 9: e102517. PMID 25019626 DOI: 10.1371/Journal.Pone.0102517 |
0.645 |
|
2014 |
Lim J, Kim J, Kang J, Jo D. Partial somatic to stem cell transformations induced by cell-permeable reprogramming factors. Scientific Reports. 4: 4361. PMID 24618595 DOI: 10.1038/Srep04361 |
0.419 |
|
2014 |
Duong T, Kim J, Ruley HE, Jo D. Correction: Cell-permeable Parkin proteins suppress Plos One. 9. DOI: 10.1371/journal.pone.0116242 |
0.37 |
|
2013 |
Lim J, Duong T, Lee G, Seong BL, El-Rifai W, Ruley HE, Jo D. The effect of intracellular protein delivery on the anti-tumor activity of recombinant human endostatin. Biomaterials. 34: 6261-71. PMID 23714245 DOI: 10.1016/J.Biomaterials.2013.05.011 |
0.695 |
|
2013 |
Lim J, Duong T, Do N, Do P, Kim J, Kim H, El-Rifai W, Ruley HE, Jo D. Antitumor activity of cell-permeable RUNX3 protein in gastric cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 680-90. PMID 23230322 DOI: 10.1158/1078-0432.Ccr-12-2692 |
0.642 |
|
2012 |
Lim J, Kim J, Duong T, Lee G, Kim J, Yoon J, Kim J, Kim H, Ruley HE, El-Rifai W, Jo D. Antitumor Activity of Cell-Permeable p18(INK4c) With Enhanced Membrane and Tissue Penetration. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 1540-1549. PMID 28157537 DOI: 10.1038/mt.2012.102 |
0.448 |
|
2012 |
Lim J, Kim J, Duong T, Lee G, Kim J, Yoon J, Kim J, Kim H, Ruley HE, El-Rifai W, Jo D. Antitumor activity of cell-permeable p18(INK4c) with enhanced membrane and tissue penetration. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 1540-9. PMID 22617107 DOI: 10.1038/Mt.2012.102 |
0.697 |
|
2012 |
Jo D, Ruley HE, El-Rifai W. Mo1612 Anti-Tumor Activity of Cell-Permeable P18ink4c With Enhanced Membrane and Tissue Penetration Gastroenterology. 142: S-641. DOI: 10.1016/S0016-5085(12)62467-6 |
0.703 |
|
2012 |
Jo D, Ruley HE, El-Rifai W. Mo1611 Traditional African and Western Diets Select Distinct Phylogenetic and Functional Colonic Microbiota Among Different Populations Mo1612 Anti-Tumor Activity of Cell-Permeable P18ink4c With Enhanced Membrane and Tissue Penetration Gastroenterology. 142: S-641. DOI: 10.1016/S0016-5085(12)62466-4 |
0.619 |
|
2012 |
Jo D, Ruley HE, El-Rifai W. Mo1552 Intracellular Delivered RUNx3 Effectively Inhibits Migration and Proliferation of Gastric Cancer Cells Gastroenterology. 142: S-626-S-627. DOI: 10.1016/S0016-5085(12)62407-X |
0.635 |
|
2011 |
Lim J, Jang G, Kang S, Lee G, Nga do TT, Phuong do TL, Kim H, El-Rifai W, Ruley HE, Jo D. Cell-permeable NM23 blocks the maintenance and progression of established pulmonary metastasis. Cancer Research. 71: 7216-25. PMID 21987726 DOI: 10.1158/0008-5472.Can-11-2015 |
0.676 |
|
2010 |
Jeon D, Kim S, Chetana M, Jo D, Ruley HE, Lin SY, Rabah D, Kinet JP, Shin HS. Observational fear learning involves affective pain system and Cav1.2 Ca2+ channels in ACC. Nature Neuroscience. 13: 482-8. PMID 20190743 DOI: 10.1038/Nn.2504 |
0.549 |
|
2005 |
Jo D, Liu D, Yao S, Collins RD, Hawiger J. Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis. Nature Medicine. 11: 892-8. PMID 16007096 DOI: 10.1038/Nm1269 |
0.314 |
|
2004 |
Lin Q, Jo D, Gebre-Amlak KD, Ruley HE. Enhanced cell-permeant Cre protein for site-specific recombination in cultured cells. Bmc Biotechnology. 4: 25. PMID 15500682 DOI: 10.1186/1472-6750-4-25 |
0.66 |
|
2003 |
Jo D, Lin Q, Nashabi A, Mays DJ, Unutmaz D, Pietenpol JA, Ruley HE. Cell cycle-dependent transduction of cell-permeant Cre recombinase proteins. Journal of Cellular Biochemistry. 89: 674-87. PMID 12858334 DOI: 10.1002/Jcb.10542 |
0.669 |
|
2001 |
Jo D, Nashabi A, Doxsee C, Lin Q, Unutmaz D, Chen J, Ruley HE. Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase. Nature Biotechnology. 19: 929-33. PMID 11581657 DOI: 10.1038/Nbt1001-929 |
0.659 |
|
Show low-probability matches. |